A Stitch in Time: Taiwan and Japan Join Hands in Providing Critical Care

HSINCHU, Taiwan–(BUSINESS WIRE)–Nov. 25, 2021 Japan has donated five batches of the AZ COVID-19 vaccine to Taiwan, and Taiwan has reciprocated by providing treatment at NTHU’s Boron Neutron Capture Therapy Center (BNCTC) for a 20-year-old Japanese woman suffering from a malignant brain tumor. The treatment was a success, and she has now returned to school. […]

Icure Acquires Drug Product Approval for World’s First Donepezil Patch for Treating Dementia of the Alzheimer Type in Korea

The world’s first donepezil patch is approved for the incrementally modified drug Launching in 2022, its availability will be expanded to the global market SEOUL, South Korea–(BUSINESS WIRE)–Nov. 16, 2021 Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of Alzheimer’s-type dementia, received a drug product […]

Novel Blood Pressure Stabilization Therapy Presented at Neuroscience 2021

Scientist Grégoire Courtine demonstrated the effectiveness of ARC Therapy during his Presidential Special Lecture EINDHOVEN, Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–Nov. 16, 2021 ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced Grégoire Courtine, Ph.D., Professor of Neuroscience at […]

Celltrion’s Monoclonal Antibody Treatment regdanvimab Approved by the European Commission for the Treatment of COVID-19

The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week (11/11/2021) Celltrion continues to discuss supply agreements with regulatory agencies and contractors in more than 30 countries in Europe, Asia and LATAM to accelerate global access […]

Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP

The CHMP positive opinion marks the first time a monoclonal antibody treatment for COVID-19 has received a recommendation for marketing authorisation from the EMA The recommendation is based on data from the global Phase III clinical trial investigating regdanvimab as a treatment for multiple variants of COVID-19, including the Delta variant Regdanvimab is the first […]

Ushering in a New Era of Medical Education at NTHU

HSINCHU, Taiwan–(BUSINESS WIRE)–Oct. 02, 2021 National Tsing Hua University’s plan to establish a post-baccalaureate program in medicine has been approved at a recent cross-ministerial meeting held at the Ministry of Education. The school’s recruitment and admission application process will begin by the end of 2021, and the first class of government-sponsored students will be enrolled […]

NTHU Researchers Develop Ultrasonic Vortex Thrombolytic Device

HSINCHU, Taiwan–(BUSINESS WIRE)–Sep. 24, 2021 As COVID-19 vaccination has raised the issue of thrombosis, Dr. Chih-Kuang Yeh, Distinguished Professor of the Department of Biomedical Engineering and Environmental Sciences, has led a research team to developed the world's first ultrasonic vortex thrombolytic device and to treat thrombosis quickly and safely. The research has been published in […]

Celltrion’s monoclonal antibody treatment for COVID-19 regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)

The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19 The approval includes an expansion of patients that can be treated with regdanvimab (CT-P59) for COVID-19 and a reduced time period for the treatment administration Celltrion continues discussions with global regulators to make regdanvimab (CT-P59) […]

RubrYc Therapeutics Announces Series A2 Preferred Equity Financing Collaboration and RTX-003 License with iBio Inc.

SAN CARLOS, Calif.–(BUSINESS WIRE)–Aug. 25, 2021 RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the research, development, and commercialization of epitope-targeted antibody therapeutics. With this transaction, iBio becomes an important strategic investor with its $7.5M […]

ZOLL and Wallaby Medical Announce Agreement to Distribute Temperature Management Products in China

CHELMSFORD, Mass.–(BUSINESS WIRE)–Aug. 23, 2021 ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Wallaby Medical Technologies, a medical device company dedicated to treating stroke and cardiac arrest, today announced they have signed a distribution agreement whereby Wallaby will manage the sales and distribution of ZOLL’s temperature management […]

iNova Pharmaceuticals Earns the Best Place To Work Global Certification

SYDNEY–(BUSINESS WIRE)–Jul. 14, 2021 iNova Pharmaceuticals, a company that markets and distributes a wide range of over-the-counter and prescription medicines in Australasia, Asia and Africa, has recently been recognised as one of the best places to work organisations in 2021. iNova achieved outstanding results in a number of assessment areas, and remains committed to using […]

Kyalio Launches DayDay Endo-Laparoscopic VR Surgical Library the First in Asia

SINGAPORE–(BUSINESS WIRE)–Jul. 08, 2021 On July 1st, 2021, Kyalio and the Endoscopic and Laparoscopic Surgeons of Asia (ELSA), a leading surgical association with over 2,600 members, jointly launched the Day-to-Day Endo-Laparoscopic Virtual Reality Surgical Library. A first in Asia, the multi-platform VR Surgical Library, which utilises real-scene Virtual Reality, addresses the importance of continuous surgical […]